IRON AMINOS TESAMORELIN 10MG
Research-grade GHRH-pathway peptide prepared for consistency and clear documentation in professional lab workflows.
Key Features
-
10mg Tesamorelin per vial (lyophilized powder)
-
≥99% purity for reproducible results
-
Sterile, sealed glass vial with tamper-evident flip cap
-
Lot/batch labeling for traceability
-
Signature Iron Aminos red-honeycomb label for quick identification
-
Diluent not included
Specifications
-
Compound: Tesamorelin (synthetic GHRH(1-44) analog with N-terminal modification for enhanced stability)
-
Pathway: Growth hormone–releasing hormone receptor agonist (incretory/pulsatile GH axis research)
-
Form / appearance: Lyophilized powder, white to off-white
-
Amount: 10mg per vial
-
Purity: ≥99%
-
Storage (lyophilized): Cool, dry, away from light
-
Storage (after reconstitution): Refrigerate; use promptly per internal SOP
What’s Included
-
1 × Tesamorelin 10mg vial (no diluent)
Handling
Use an appropriate sterile diluent and aseptic technique. Follow your lab’s SOPs for reconstitution, aliquoting, labeling, and disposal.
Research Snapshot
-
GHRH-receptor activation by tesamorelin increases pulsatile GH and downstream IGF-1 in controlled studies, with protocol-dependent endocrine responses.
-
Peer-reviewed trials in metabolic research report reductions in visceral adipose tissue (VAT) and favorable shifts in certain lipid markers during active treatment; effects are exposure- and time-dependent.
-
Study-reported adverse events include injection-site reactions, arthralgia, edema, paresthesia, and transient glucose intolerance; IGF-1 elevation is commonly monitored in protocols.
-
Investigational use only; findings vary by dose, route, titration schedule, and cohort.
Compliance
For research use only. Not for human consumption.
Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.
